Abstract:OBJECTIVE:To investigate the therapeutic effects of pulmonary surfactant (PS) on smoking-induced lung injury in rats.METHODS:Thirty male Wistar rats were randomly divided into four groups: normal control group (n = 8, killed by the end of the 7th week), 3-week smoking group (n = 8, in haling mainstream smoke of cigarette for 3 weeks and killed by the end of the 3rd week), 7-week smoking group (n = 8, in haling mainstream smoke of cigarette for 7 weeks and killed by the end of the 7th week), and PS treatment group (n = 6, inhaling mainstream smoke of cigarette for 7 weeks and given PS 25 mg/kg via trachea per week for 4 weeks since the end of the 3rd week of smoking, totally 5 times, and then killed by the end of the 7th week). The histological changes of respiratory bronchioles were observed by light microscopy and transmission electron microscopy. The airway resistance in expiratory phase was tested by pulmonary function test apparatus. The expression of Clara cell 16KD protein (CC16) mRNA and SP-C mRNA in lung tissue was determined by RT-PCR and the expression of CC16 protein in bronchiole epithelial cells was determined by immunohistochemistry.RESULTS:The proportion of Clara cell to the respiratory bronchiole epithelial cells was 62% in the normal controls, 40% in the 3-week smoking group, 33% in the 7-week smoking group, and 56% in the PS treatment group (significantly lower in comparison with that in the 7-week group, P < 0.05). Degeneration of Clara cells, hyperplasis of type II pneumocytes and increase of area of smooth muscle in bronchioles were observed in the three smoking groups, however, such changes were the most distinct in the 7-week smoking group and the less distinct in the PS treatment group (P < 0.05). In comparison with those in the normal control group, the expression of CC16 mRNA, SP-C mRNA and CC16 protein were lower in the three smoking groups. However, the expressions of CC16 mRNA and the expression of SP-C mRNA in the PS treatment group were significantly higher than those in the 7-week smoking group (11.8 +/- 5.1 vs 3.0 +/- 0.9, and 8.5 +/- 3.4 vs 2.5 +/- 0.9, both P < 0.05). The mean area of smooth muscle in bronchioles with the diameter less than 200 micro m was significantly larger than that in the control group, however, the mean area in the PS treatment group was significantly less than that in the 7-week smoking group (P < 0.05). The airway resistance in the control group (1.62 +/- 0.08 cmH(2)O. L(-1). s(-1)) was lower than those in the 3 smoking groups, however, the airway resistance in the PS treatment group was significantly lower than that in the 7-week group (1.70 +/- 0.07 cmH(2)O. L(-1). s(-1) vs 2.98 +/- 0.65 cmH(2)O. L(-1). s(-1), P < 0.05).CONCLUSION:PS is effective in alleviating smoking-induced lung injury in rats. One of the mechanisms might be attenuation of the damage in Clara cells and type II pneumocytes due to cigarette smoking.

Effect of TGF-β1 on Cigarette Smoke-Induced Pulmonary Hypertension in Hamster Lungs

Effect of Cigarette Smoke on Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease in Hamster

Effect of AngII and TGF-β1 on cigarette smoke-induced pulmonary arterioles remodeling

Role of Chymase in Cigarette Smoke-Induced Pulmonary Artery Remodeling and Pulmonary Hypertension in Hamsters

Role of chymase in cigarette smoke-induced pulmonary hypertension in hamsters

Expression of Chymase in Pulmonary Artery Reconstruction of Pulmonary Hypertension

Effect of SB203580 on Cigarette Smoke Exposure to Asthmatic Rats

Liver toxicity in rats after subchronic exposure to HTP aerosol and cigarette smoke

WNT/β-catenin Signaling Regulates Cigarette Smoke-Induced Airway Inflammation Via the PPARδ/p38 Pathway

Ginsenoside Rg1 Ameliorates Cigarette Smoke-Induced Airway Fibrosis by Suppressing the TGF-β1/Smad Pathway In Vivo and In Vitro

Ginsenoside Rg1 Ameliorates Cigarette Smoke-Induced Airway Fibrosis By Suppressing The Tgf-Beta 1/Smad Pathway In Vivo And In Vitro

Ginsenoside Rg1 Attenuates Cigarette Smoke-Induced Pulmonary Epithelial-Mesenchymal Transition via Inhibition of the TGF-<i>β</i>1/Smad Pathway

Differences in Airway Remodeling and Emphysematous Lesions between Rats Exposed to Smoke from New-Type and Conventional Tobacco Varieties

Effect of epigallocatechin gallate(EGCG) on the expression of TGF-β1 and Smad2/7mRNA of lung tissue of the experimental lung pulmonary fibrosis in rats

Ginsenoside Rg1 Attenuates Cigarette Smoke-Induced Pulmonary Epithelial-Mesenchymal Transition via Inhibition of the TGF- β 1/Smad Pathway.

Exposure to Cigarette Smoke Downregulatesβ2-Adrenergic Receptor Expression and Upregulates Inflammation in Alveolar Macrophages

Mesenchymal stem cells reduce cigarette smoke-induced inflammation and airflow obstruction in rats via TGF-β1 signaling.

Therapeutic Effects of Pulmonary Surfactant on Smoking-Induced Lung Injury in Rats, an Experimental Study

The role of transforming growth factor-β1 in airway vascular remodeling of asthmatic mice

The Effect of Huqihuoxue Decoct on TGF-β_1 and Pathological Change in Pulmonary Fibrosis Rats Model

Effects of Tiotropium Bromide on Airway Inflammation in a Rat Model with COPD